Part 9: acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment …
RE O'Connor, L Bossaert, HR Arntz, SC Brooks… - Circulation, 2010 - Am Heart Assoc
Note From the Writing Group: Throughout this article, the reader will notice combinations of
superscripted letters and numbers (eg,“Chest Pain Observation Units ACS-005A”). These …
superscripted letters and numbers (eg,“Chest Pain Observation Units ACS-005A”). These …
Antiplatelet agents for chronic kidney disease
P Natale, SC Palmer, VM Saglimbene… - Cochrane Database …, 2022 - cochranelibrary.com
Background Antiplatelet agents are widely used to prevent cardiovascular events. The risks
and benefits of antiplatelet agents may be different in people with chronic kidney disease …
and benefits of antiplatelet agents may be different in people with chronic kidney disease …
[HTML][HTML] Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis
AD Shah, O Nicholas, AD Timmis, G Feder… - PLoS …, 2011 - journals.plos.org
Background Low haemoglobin concentration has been associated with adverse prognosis
in patients with angina and myocardial infarction (MI), but the strength and shape of the …
in patients with angina and myocardial infarction (MI), but the strength and shape of the …
Part 9: acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment …
L Bossaert, RE O'Connor, HR Arntz… - …, 2010 - resuscitationjournal.com
The International Liaison Committee on Resuscitation (ILCOR) ACS-MI Task Force included
expert reviewers from Africa, Asia, Australia, Europe, North America, and South America …
expert reviewers from Africa, Asia, Australia, Europe, North America, and South America …
[HTML][HTML] Safety and efficacy of bivalirudin with glycoprotein IIb/IIIa for high-risk percutaneous coronary intervention
NV Deshpande, R Pratiti, P Admane, D Mukherjee… - Indian heart …, 2012 - Elsevier
Aims The aim of the study was to assess the safety and efficacy of Bivalirudin+ Glycoprotein
(Gp) IIb/IIIa inhibitor as compared to unfractionated Heparin (UFH)+ Gp IIb/IIIa inhibitor in …
(Gp) IIb/IIIa inhibitor as compared to unfractionated Heparin (UFH)+ Gp IIb/IIIa inhibitor in …
Beyond the platelet count: heparin antibodies as independent risk predictors
WK Stribling, TF Slaughter, TT Houle, DC Sane - American heart journal, 2007 - Elsevier
A major potential side effect of heparin is immunogenicity, eliciting antibody development to
a protein complex comprised of platelet factor 4 and heparin. Nevertheless, the clinical …
a protein complex comprised of platelet factor 4 and heparin. Nevertheless, the clinical …
[HTML][HTML] αIIbβ3 priming and clustering by orally active and intravenous integrin antagonists
RR Hantgan, MC Stahle, JH Connor, RF Connor… - Journal of Thrombosis …, 2007 - Elsevier
Background: Drugs that block platelet–platelet and platelet–fibrin interactions via the α IIb β
3 (glycoprotein IIb/IIIa) receptor are used daily in patients undergoing percutaneous …
3 (glycoprotein IIb/IIIa) receptor are used daily in patients undergoing percutaneous …
急性冠脉综合征的治疗进展
李为民， 王政 - 国际心血管病杂志, 2006 - cqvip.com
急性冠状动脉综合征(acute coronary syndromes, ACS) 是以冠状动脉粥样硬化斑块破溃,
继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征, 包括不稳定型心绞痛 …
继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征, 包括不稳定型心绞痛 …
Bleeding risk and outcomes of bivalirudin versus glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated heparin in patients having percutaneous …
DH Steinberg, P Shah, T Kinnaird, TLP Slottow… - The American journal of …, 2008 - Elsevier
For patients undergoing elective percutaneous coronary intervention (PCI), procedural
anticoagulation with bivalirudin was previously shown to significantly reduce bleeding …
anticoagulation with bivalirudin was previously shown to significantly reduce bleeding …
急性冠状动脉综合征的诊治进展
阮长武， 陈锐 - 心血管病学进展, 2009 - cqvip.com
急性冠状动脉综合征(acute coronary syndrome, ACS) 是近年来提出的新概念, 按ST
段抬高与否, 分为ST 段抬高及非ST 段抬高的ACS. ST 段抬高的ACS 主要演变为Q …
段抬高与否, 分为ST 段抬高及非ST 段抬高的ACS. ST 段抬高的ACS 主要演变为Q …